Religare Enterprises is a holding company that derives most of its value from Care Health Insurance, India's second largest standalone health insurer, alongside three financial services businesses: Religare Broking, Religare Finvest and Religare Housing Finance. In Q1 FY27, Care wrote gross written premium of INR3,247 crores, up 37% year on year, with retail health premium growing 45%. Its market share stood at 6.7% of the industry and 24% within the standalone health insurer segment, with retail health at 12.6% of industry and 21.6% among standalone insurers. Care's combined ratio under Ind-AS was 102.6%, down 30 basis points from the prior year, and its gross operating expense ratio improved 100 basis points to 31.2%. The financial services segment is much smaller: broking generated INR99.6 crores of income and INR10 crores of PBT, Finvest had a core SME book of INR53 crores, and housing finance had AUM INR247 crores with a quarterly loss of INR5 crores. This structure means the near-term earnings engine is Care, while financial services are positioned for a restart rather than current contribution.
Care's economics persist because of distribution and renewal behavior, not because the industry is easy. The proprietary agency channel contributed about 45% of Care's GWP, with a network of roughly 4.11 lakh agents after adding about 50,000 in FY26. Digital infrastructure reinforces switching costs: 96% of policies are issued digitally, 87% of cashless claims are processed in under an hour, and the mobile app has 12.5 million installations with 1.2 million monthly active users. Care's claim settlement ratio is 97%, and retail mix improved 3% year on year, which supports higher renewal persistency and lower acquisition cost per policy. The same cannot be said for the rest of the group. Finvest has been under a lending embargo for six to seven years and its loan book is only INR53 crores; broking operates in a cluttered market where active clients declined. Thus the moat is concentrated in Care's brand, distribution and claims technology, while the lending and broking businesses will initially be commodity operators competing on capital and execution.
The inflection is capital deployment and management change. Care received INR150 crores of rights issue proceeds in Q1 FY27 and INR200 crores of sub-debt in August 2026; earlier rights issues in September 2025 and June 2026 brought in over INR365 crores from REL and the promoter. Promoter holding is now around 30.3%, and warrants worth INR881 crores are due for conversion by March 2027. RFL, with cash over INR600 crores and tangible net worth of INR915 crores, is expected to commence lending in the next three to four months after seven years of regulatory cleanup, and management has said its capital base supports ambitions for a combined INR10,000-15,000 crore book across lending and housing finance. Housing finance has INR250 crores of committed additional capital and targets profitability within 12 to 18 months from mid-2026. Eighteen to twenty-four months from now, Care should be writing GWP around INR16,000-17,500 crores if it sustains the guided 18-24% growth from the FY26 base of INR11,417 crores, with combined ratio near 100%. The demerger of financial services into a separately listed RFL was targeted for Q1 FY28, but the RBI did not accede to the scheme in mid-2026, so that milestone has slipped and remains subject to regulatory engagement.
Management has a track record of setting operating targets and then reiterating or beating them. In May 2026, management committed to Care's combined ratio reaching near 100% in two years, sustainable GWP growth of 18-24%, housing finance profitability in 12-18 months, and product launches at Finvest within the next couple of quarters. The August 2026 call reaffirmed the combined ratio target and specified that Finvest would start lending in three to four months. Care's Q1 FY27 growth of 37% exceeded the guided range, combined ratio improved 30 basis points, broking PBT rose 47% to INR10 crores, and Finvest reported PAT of INR15 crores with 98% collection efficiency. However, the regulatory milestone failed: the demerger scheme was approved by boards in February 2026, but the RBI did not accede and provided no rationale, so completion no longer has a firm date. Capital allocation has been consistent with promises: sub-debt issued, rights proceeds infused, and INR250 crores committed to housing finance. The gap between operational delivery and regulatory resolution is the core risk.
The quantified path to mid-2028 is a Care combined ratio falling from 102.6% to around 100%, which on a roughly INR16,000-17,500 crore premium base would move underwriting from near breakeven to meaningful profit contribution, alongside continued 18-24% premium growth. Finvest and housing finance would need to deploy their combined capital base of roughly INR1,000 crores into earning assets; even if lending reaches only a fraction of the stated INR10,000-15,000 crore ambition, it would dwarf the current INR53 crore book. The single most important falsifier is whether Care can maintain its solvency ratio above the 1.5 regulatory floor while growing; it was 1.58 in June 2026, and the INR200 crore sub-debt was raised to address that. If capital is consumed by premium growth faster than renewals bring operating leverage, the 100% combined ratio target slips. The tension between strong retail growth and a combined ratio above 100 is structural, not cyclical: it depends on renewal cost efficiency and proprietary distribution, both of which have improved but still need to work over the next two years. The other watchpoint is RFL's lending restart, which after a six-year hiatus carries execution risk in technology and underwriting.
companyname: Religare Enterprises Limited ticker: RELIGARE sector: Financial Services / Insurance Religare Enterprises Limited (REL) is a Core Investment Company registered with the Reserve Bank of India, structured as the listed holding company for four financial services businesses: health insurance, retail broking, MSME lending, and affordable housing finance. The Burman Group became promoter in February 2025 after completing an open offer, and the company has since moved from "recovery to r...
Read the full report →margin expansion, geographic expansion, management upgrade
Care Health Insurance's combined ratio guided to improve to near 100% within 2 years driven by operating leverage and renewal cost efficiency
Guidance no_dataGet valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Religare Enterprises Limited and 4,900+ companies.
5-day free pass. No card required.